For the first time, the fully mechanical heart made by BiVACOR, which uses the same technology as high-speed rail lines, has been implanted inside a human being. The feat marks a major step in ...

The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.

BiVACOR's Total Artificial Heart has been implanted, offering hope for heart failure patients. Kurt “CyberGuy" Knutsson has more on the quantum leap in cardiac care technology.

BiVACOR’s founder, Australian bioengineer Daniel Timms, who invented the device following his father’s death from heart disease, said it was “exhilarating to see decades of work come to ...

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, a clinical-stage medical device company, announced today, the successful completion of the first phase of the FDA Early Feasibility Study, with ...

The BiVACOR implant worked for 105 days while he awaited a human transplant. Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent every weekday. Search for: ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial Heart (TAH), as a potential bridge to transplant for the adult ...

The creation of such a device, today known as the Bivacor Total Artificial Heart, was once inconceivable to almost everyone—but not Bud Frazier. I spoke with Frazier at his office at THI, ...

The Texas Heart Institute (THI), BiVACOR®, a clinical-stage medical device company, Baylor St. Luke’s Medical Center and Baylor College of Medicine announced today the successful first-in-human ...

The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.

BiVACOR’s founder, Australian bioengineer Daniel Timms, who invented the device following his father’s death from heart disease, said it was “exhilarating to see decades of work come to ...